AU3989801A - Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis - Google Patents

Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis

Info

Publication number
AU3989801A
AU3989801A AU3989801A AU3989801A AU3989801A AU 3989801 A AU3989801 A AU 3989801A AU 3989801 A AU3989801 A AU 3989801A AU 3989801 A AU3989801 A AU 3989801A AU 3989801 A AU3989801 A AU 3989801A
Authority
AU
Australia
Prior art keywords
angiogenesis
modulation
regulation
cell surface
endothelial cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU3989801A
Other languages
English (en)
Inventor
Thomas O Daniel
Takamune Takahashi
Raymond Mernaugh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vanderbilt University
Original Assignee
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/516,728 external-priority patent/US7176289B1/en
Application filed by Vanderbilt University filed Critical Vanderbilt University
Publication of AU3989801A publication Critical patent/AU3989801A/xx
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU3989801A 2000-03-01 2001-02-27 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis Withdrawn AU3989801A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/516,728 US7176289B1 (en) 1998-09-11 2000-03-01 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
PCT/US2001/006178 WO2001064750A2 (en) 2000-03-01 2001-02-27 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis

Publications (1)

Publication Number Publication Date
AU3989801A true AU3989801A (en) 2001-09-12

Family

ID=24056849

Family Applications (1)

Application Number Title Priority Date Filing Date
AU3989801A Withdrawn AU3989801A (en) 2000-03-01 2001-02-27 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis

Country Status (7)

Country Link
EP (1) EP1261644A2 (xx)
JP (1) JP2004507210A (xx)
AU (1) AU3989801A (xx)
CA (1) CA2401621A1 (xx)
IL (2) IL151370A0 (xx)
MX (1) MXPA02008462A (xx)
WO (1) WO2001064750A2 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7205121B2 (en) * 2002-11-26 2007-04-17 Cold Spring Harbor Laboratory DEP-1 receptor protein tyrosine phosphatase interacting proteins and related methods
US20050287140A1 (en) * 2004-04-23 2005-12-29 Amgen Inc. Antibodies to angiogenesis inhibiting domains of CD148
WO2005117970A2 (en) * 2004-04-23 2005-12-15 Amgen, Inc. Antibodies of angiogenesis inhibiting domains of cd148
EP4034561A2 (en) * 2019-09-27 2022-08-03 Starkage Therapeutics Senescent cell-associated antigen-binding domains, antibodies and chimeric antigen receptors comprising the same, and uses thereof
US11723926B2 (en) 2019-09-27 2023-08-15 Starkage Therapeutics Senescent cell-associated antigen-binding domains, antibodies and chimeric antigen receptors comprising the same, and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030008A1 (en) * 1994-05-03 1995-11-09 Cold Spring Harbor Laboratory Density enhanced protein tyrosine phosphatases
US6248327B1 (en) * 1998-09-11 2001-06-19 Vanderbilt University Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis

Also Published As

Publication number Publication date
IL151370A0 (en) 2003-04-10
WO2001064750A3 (en) 2002-01-24
CA2401621A1 (en) 2001-09-07
MXPA02008462A (es) 2004-05-14
IL151370A (en) 2010-11-30
EP1261644A2 (en) 2002-12-04
JP2004507210A (ja) 2004-03-11
WO2001064750A2 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
EP1109578A4 (en) MODULATION OF RECEPTOR ACTIVITY ON THE ENDOTHEL CELL SURFACE IN CONNECTION WITH THE REGULATION OF ANGIOGENESIS
SG93898A1 (en) Porous materials
SG85162A1 (en) Absorbent article with surface structure
IL138267A0 (en) Upper body support
HK1046542A1 (zh) 實用打火機
EP1286146A4 (en) LAST CELL
GB9904905D0 (en) Cells
HK1052380B (zh) 實用的點火器
HK1048355A1 (en) Utility lighter
AU3989801A (en) Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
HU0002634D0 (en) Sustained surface scrubbing
AU7061401A (en) Chimeric promoters for controlling expression in smooth muscle cells
GB9918631D0 (en) The cane support
GB2356045B (en) Energy saving in buildings
GB9917180D0 (en) Cell surface receptor
GB9904466D0 (en) Decking hanger
AU4025100A (en) Immortal microvascular endothelial cells and uses thereof
GB9905013D0 (en) Plant decking
TW401839U (en) Improved top structure
TW387459U (en) Elevated floor-board support structure
TW375088U (en) Embossment structure for the surface of the hollow shapes
TW427367U (en) Cloth surface structure
IL135101A0 (en) Liquid capacity controller
GB9901650D0 (en) Surface construction
TW387458U (en) Floor-board support structure

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired
NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 31 AUG 2008 TO 30 JUN 2009 IN WHICH TO PAY A RENEWAL FEE HAS BEEN FILED .

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY A RENEWAL FEE HAS BEEN EXTENDED TO 30 JUN 2009.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired